Z. Efstathiadou

发表

Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.

A. Tsatsoulis, H. Milionis, M. Elisaf, 2003, Thyroid : official journal of the American Thyroid Association.

Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules

S. Polyzos, Z. Efstathiadou, A. Kourtis, 2008, Journal of Cancer Research and Clinical Oncology.

Serum homocysteine, folate and vitamin B12 in patients with Paget’s disease of bone: the effect of zoledronic acid

S. Polyzos, E. Terpos, G. Arsos, 2010, Journal of Bone and Mineral Metabolism.

A study of the growth-promoting and metabolic effects of growth hormone (GH) in a patient with the "growth without GH" syndrome.

A. Tsatsoulis, Z. Efstathiadou, M. Pavlou, 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations.

S. Polyzos, M. Yavropoulou, P. Makras, 2021, Maturitas.

Long‐term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis

I. Godsland, D. Johnston, Z. Efstathiadou, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Rate of change and instability in body mass index, insulin resistance, and lipid metabolism as predictors of atherosclerotic vascular disease.

I. Godsland, D. Johnston, Z. Efstathiadou, 2007, The Journal of clinical endocrinology and metabolism.

Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.

D. Goulis, S. Polyzos, A. Anastasilakis, 2008, Endocrine journal.

No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial

S. Polyzos, A. Anastasilakis, Z. Efstathiadou, 2009, Clinical endocrinology.

De novo autoimmune hepatitis associated with PTH(1–34) and PTH(1–84) administration for severe osteoporosis in a liver transplant patient

P. Hytiroglou, Z. Efstathiadou, M. Kita, 2012, Osteoporosis International.

Unusual case of Cowden‐like syndrome, neck paraganglioma, and pituitary adenoma

Z. Efstathiadou, M. Kita, P. Anagnostis, 2014, Head & neck.

Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist.

A. Tsatsoulis, Z. Efstathiadou, Zoe Efstathiadou, 2001, Fertility and sterility.

The Sp1 COLIA1 Gene Polymorphism, and Not Vitamin D Receptor or Estrogen Receptor Gene Polymorphisms, Determines Bone Mineral Density in Postmenopausal Greek Women

J. Ioannidis, A. Tsatsoulis, I. Georgiou, 2001, Osteoporosis International.

Irisin in metabolic diseases

C. Mantzoros, J. Kountouras, S. Polyzos, 2018, Endocrine.

Associations of estrogen receptor alpha and Beta gene polymorphisms with lipid levels and insulin resistance in men.

S. Polyzos, A. Bargiota, Z. Efstathiadou, 2015, Metabolism: clinical and experimental.

Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus.

S. Polyzos, P. Papaioannidou, A. Goulas, 2020, Diabetes & metabolic syndrome.

Acromegaly: presentation, morbidity and treatment outcomes at a single centre

S. Polyzos, S. Katergari, Z. Efstathiadou, 2011, International journal of clinical practice.

Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly

D. Goulis, Z. Efstathiadou, D. Farmakiotis, 2008, Clinical endocrinology.

Correlation of estrogen receptor beta gene polymorphisms with spinal bone mineral density in peri- and post-menopausal Greek women.

A. Tsatsoulis, E. Zintzaras, Z. Efstathiadou, 2006, Maturitas.

Benefits and Limitations of TKIs in Patients with Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis

K. Toulis, M. Alevizaki, K. Kotsa, 2019, European Thyroid Journal.

Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?

H. Milionis, M. Elisaf, Z. Efstathiadou, 2001, European journal of endocrinology.

The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes

M. McCarthy, I. Godsland, D. Johnston, 2005, Diabetologia.

Effect of Exogenous Intermittent Recombinant Human PTH 1–34 Administration and Chronic Endogenous Parathyroid Hormone Excess on Glucose Homeostasis and Insulin Sensitivity

A. Anastasilakis, Z. Efstathiadou, A. Slavakis, 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.

S. Polyzos, P. Makras, A. Anastasilakis, 2015, Metabolism: clinical and experimental.

Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget’s disease

S. Polyzos, E. Terpos, G. Arsos, 2010, Journal of Bone and Mineral Metabolism.

Sustained clinical inactivity and stabilization of GH/IGF-1 levels in an acromegalic patient after discontinuation of somatostatin analogue treatment.

S. Polyzos, Z. Efstathiadou, A. Avramidis, 2008, Endocrine journal.

Long term follow-up of patients with adrenal incidentalomas--a single center experience and review of the literature.

S. Polyzos, Z. Efstathiadou, M. Kita, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1.

S. Polyzos, E. Terpos, G. Arsos, 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience

S. Polyzos, Z. Efstathiadou, M. Kita, 2012, Pituitary.

Gastrectomy and Osteomalacia: An Association Not to Be Forgotten

A. Tsatsoulis, Z. Efstathiadou, S. Bitsis, 2000, Hormone Research in Paediatrics.

Pituitary incidentalomas: a single‐centre experience

S. Polyzos, Z. Efstathiadou, M. Kita, 2011, International journal of clinical practice.

Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget’s disease of bone

S. Polyzos, G. Arsos, Z. Efstathiadou, 2008, Journal of Bone and Mineral Metabolism.

Non-Functioning Pituitary Adenomas: A Single Center Experience

S. Polyzos, Z. Efstathiadou, M. Kita, 2011, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?

Z. Efstathiadou, M. Kita, P. Anagnostis, 2014, Endocrine.

Oxidative Stress and Reduced Antioxidative Status, along with Endothelial Dysfunction in Acromegaly

S. Polyzos, Z. Efstathiadou, M. Kita, 2012, Hormone and Metabolic Research.

The ongoing challenge of discrepant growth hormone and insulin‐like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta‐analysis

M. Alevizaki, A. Bargiota, S. Tsagarakis, 2016, Clinical endocrinology.

Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis

S. Polyzos, P. Makras, A. Anastasilakis, 2015, Expert opinion on investigational drugs.

Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis

M. Alevizaki, A. Bargiota, S. Tsagarakis, 2015, Pituitary.

Correction to: A mutation in NOTCH2 gene first associated with Hajdu–Cheney syndrome in a Greek family: diversity in phenotype and response to treatment

S. Polyzos, I. Georgiou, Z. Efstathiadou, 2020, Endocrine.

A mutation in NOTCH2 gene first associated with Hajdu–Cheney syndrome in a Greek family: diversity in phenotype and response to treatment

S. Polyzos, I. Georgiou, Z. Efstathiadou, 2020, Endocrine.

Could Lipid Profile be Used as a Marker of Autonomous Cortisol Secretion in Patients with Adrenal Incidentalomas?

G. Mintziori, Z. Efstathiadou, M. Kita, 2018, Hormone and Metabolic Research.

Primary adrenal lymphoma presenting as Addison's disease. Case report and review of the literature.

A. Saratzis, Z. Efstathiadou, A. Avramides, 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Association of Collagen Iα 1 Sp1 Polymorphism with the Risk of Prevalent Fractures: A Meta‐Analysis

J. Ioannidis, A. Tsatsoulis, Z. Efstathiadou, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Head‐to‐head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial

S. Polyzos, A. Anastasilakis, Z. Efstathiadou, 2008, International journal of clinical practice.

Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women.

A. Tsatsoulis, Z. Efstathiadou, A. Challa, 2004, Maturitas.

Turner's syndrome with concomitant hypopituitarism: case report.

A. Tsatsoulis, Z. Efstathiadou, 2000, Human reproduction.

Turner ’ s syndrome with concomitant hypopituitarism

A. Tsatsoulis, Z. Efstathiadou, 2000 .

The use of demographic, ultrasonographic and scintigraphic data in the diagnostic approach of thyroid nodules.

S. Polyzos, Z. Efstathiadou, A. Benos, 2008, Experimental and clinical endocrinology & diabetes.

Zoledronic Acid on Serum Dickkopf-1 , Osteoprotegerin , and RANKL in Patients with Paget ’ s Disease

E. Terpos, V. Pavlidou, G. Arsos, 2009 .

Intrasellar Rathke’s Cleft Cyst and Acromegaly: an Unusual Coincidence

Z. Efstathiadou, M. Poulasouchidou, Chrisanthi Zouli, 2015, Experimental and Clinical Endocrinology & Diabetes Reports.

The ongoing challenge of discrepant growth hormone and insulin‐like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta‐analysis

M. Alevizaki, A. Bargiota, S. Tsagarakis, 2016, Clinical endocrinology.

The effect of L‐thyroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism

S. Katergari, Z. Efstathiadou, A. Slavakis, 2014, International journal of clinical practice.

Subclinical hypothyroidism and diabetic nephropathy. Could L-thyroxine replacement therapy be of value?

Z. Efstathiadou, M. Kita, P. Anagnostis, 2014, Endocrine journal.

Subclinical hypothyroidism and diabetic nephropathy. Could L-thyroxine replacement therapy be of value? [Letter to the Editor]

Z. Efstathiadou, M. Kita, P. Anagnostis, 2014 .

Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.

S. Polyzos, P. Makras, A. Anastasilakis, 2015, Metabolism: clinical and experimental.